Total Payments
$2,597
2024 Payments
$832.22
Companies
13
Transactions
99
Medicare Patients
526
Medicare Billing
$54,531
Payment Breakdown by Category
Food & Beverage$2,441 (94.0%)
Education$155.99 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,441 | 97 | 94.0% |
| Education | $155.99 | 2 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,344 | 58 | $0 (2024) |
| Janssen Biotech, Inc. | $538.24 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $182.01 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $143.56 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $139.43 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $93.52 | 1 | $0 (2024) |
| PFIZER INC. | $30.39 | 2 | $0 (2022) |
| Braintree Laboratories, Inc. | $29.76 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $25.05 | 1 | $0 (2024) |
| QOL Medical, LLC | $24.01 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $832.22 | 20 | Janssen Biotech, Inc. ($302.75) |
| 2023 | $609.13 | 25 | ABBVIE INC. ($214.13) |
| 2022 | $804.67 | 29 | ABBVIE INC. ($651.74) |
| 2021 | $351.10 | 25 | AbbVie Inc. ($209.13) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $43.28 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: VIROLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.61 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $93.52 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: VIROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Immunology | ||||||
| 05/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: VIROLOGY | ||||||
| 04/16/2024 | Digestive Care, Inc. | Pertzye (Drug), Pertzye, Pertzye | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| Category: Gastroenterology | ||||||
| 04/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/28/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/21/2024 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: GI COLON PREP | ||||||
| 01/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: VIROLOGY | ||||||
| 12/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: Immunology | ||||||
| 12/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: VIROLOGY | ||||||
| 10/27/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $40.15 | General |
| Category: Immunology | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 96 | 128 | $49,213 | $9,311 |
| 2022 | 2 | 134 | 185 | $65,605 | $14,474 |
| 2021 | 2 | 152 | 199 | $69,397 | $16,674 |
| 2020 | 3 | 144 | 196 | $54,739 | $14,072 |
Total Patients
526
Total Services
708
Medicare Billing
$54,531
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 109 | $40,112 | $7,599 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,101 | $1,712 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 161 | $54,901 | $12,135 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $10,704 | $2,339 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 163 | $53,953 | $13,083 | 24.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $15,444 | $3,590 | 23.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 109 | 157 | $41,762 | $10,616 | 25.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $7,657 | $1,949 | 25.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 20 | $5,320 | $1,507 | 28.3% |
About Debra Fuller, ARNP
Debra Fuller, ARNP is a Family healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1093095663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Debra Fuller, ARNP has received a total of $2,597 in payments from pharmaceutical and medical device companies, with $832.22 received in 2024. These payments were reported across 99 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,441).
As a Medicare-enrolled provider, Fuller has provided services to 526 Medicare beneficiaries, totaling 708 services with total Medicare billing of $54,531. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Spokane, WA
- Active Since 08/26/2011
- Last Updated 11/03/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1093095663
Products in Payments
- MAVYRET (Drug) $463.67
- STELARA (Biological) $346.63
- SKYRIZI (Biological) $342.48
- CREON (Drug) $286.42
- TREMFYA (Drug) $191.61
- ENTYVIO (Biological) $182.01
- DUPIXENT (Biological) $143.56
- XIFAXAN (Drug) $139.43
- LINZESS (Drug) $115.37
- INJECTAFER (Drug) $93.52
- HUMIRA (Biological) $78.40
- RINVOQ (Biological) $57.27
- XELJANZ (Drug) $30.39
- SUTAB (Drug) $29.76
- DIFICID (Drug) $25.05
- SUCRAID (Drug) $24.01
- Pertzye (Drug) $18.01
- OCALIVA (Drug) $15.95
- ZENPEP (Drug) $13.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Spokane
Zelda Swain
Family — Payments: $74,304
Family $74,304
Lance Varns, Arnp, Np-C, ARNP, NP-C
Family — Payments: $8,369
Family $8,369
Favor Osakwe, Pmhnp-Bc, Fnp, Aprn, PMHNP-BC, FNP, APRN
Family — Payments: $7,367
Family $7,367
Jennifer Banks, Arnp, ARNP
Family — Payments: $5,339
Family $5,339
Miss. Margaret Kyakuwa, Fnp-Bc, FNP-BC
Family — Payments: $4,737
Family $4,737
Ruth Mollet, Np-C, NP-C
Family — Payments: $4,372
Family $4,372